Shushan Hovsepyan: Have you checked the MASCC/ESMO update on CT-induced nausea/vomiting?

Shushan Hovsepyan, Clinical Research Coordinator at the Yeolyan Hematology and Oncology Center, shared on X/Twitter:

”Have you checked the MASCC/ESMO update on CT-induced nausea/vomiting?

• High-dose CT and stem-cell transplant = 5-HT3 antagonist+dexa+aprepitant,
• Multi-day Cisplatin= 5-HT3antagonist+dexa +aprepitant +olanzapine,
• Breakthrough N/V=single dose olanzapine 3day.”

Read further.
Source: Shushan Hovsepyan/X